AstraZeneca to supply nine million more vaccine doses, says European Union

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"1">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>Pharmaceutical company AstraZeneca has agreed to supply nine million additional doses of its coronavirus vaccine to the European Union during the first quarter&comma; the bloc’s executive branch said on Sunday&period;<&sol;p>&NewLine;<p>The new target of 40 million doses by the end of March is still only half what the British&sol;Swedish company had originally aimed for&comma; triggering a spat between AstraZeneca and the EU last week&period;<&sol;p>&NewLine;<p>Speaking after a call with seven vaccine makers on Sunday&comma; European Commission President Ursula von der Leyen said that AstraZeneca would also begin deliveries one week sooner than scheduled and expand its manufacturing capacity in Europe&period;<&sol;p>&NewLine;<blockquote class&equals;"twitter-tweet" data-width&equals;"550" data-dnt&equals;"true">&NewLine;<p lang&equals;"en" dir&equals;"ltr">Step forward on vaccines&period;<a href&equals;"https&colon;&sol;&sol;twitter&period;com&sol;AstraZeneca&quest;ref&lowbar;src&equals;twsrc&percnt;5Etfw">&commat;AstraZeneca<&sol;a> will deliver 9 million additional doses in the first quarter &lpar;40 million in total&rpar; compared to last week’s offer &amp&semi; will start deliveries one week earlier than scheduled&period;<&sol;p>&NewLine;<p>The company will also expand its manufacturing capacity in Europe&period;<&sol;p>&NewLine;<p>&mdash&semi; Ursula von der Leyen &lpar;&commat;vonderleyen&rpar; <a href&equals;"https&colon;&sol;&sol;twitter&period;com&sol;vonderleyen&sol;status&sol;1355942468001411072&quest;ref&lowbar;src&equals;twsrc&percnt;5Etfw">January 31&comma; 2021<&sol;a><&sol;p><&sol;blockquote>&NewLine;<p><script async src&equals;"https&colon;&sol;&sol;platform&period;twitter&period;com&sol;widgets&period;js" charset&equals;"utf-8"><&sol;script><&sol;p>&NewLine;<p>Ms Von der Leyen&comma; who has come under intense pressure over the European Commission’s handling of the vaccine orders in recent days&comma; tweeted&colon; &OpenCurlyDoubleQuote;Step forward on vaccines&period;”<&sol;p>&NewLine;<p>The EU is far behind Britain and the United States in getting its population of 450 million vaccinated against the virus&period;<&sol;p>&NewLine;<p>The slow rollout has been blamed on a range of national problems as well as delayed approval of the vaccines compared to elsewhere and an initial shortage of supply&period;<&sol;p>&NewLine;<p>The announcement last week that AstraZeneca would initially only supply 31 million doses to the EU’s 27 member states due to production problems triggered a fierce dispute between the two sides&comma; with officials in Brussels saying they feared the company was treating the bloc unfairly compared to other customers&comma; such as the United Kingdom&period;<&sol;p>&NewLine;<p>On Friday&comma; hours after regulators authorised the vaccine for use across the EU&comma; the commission announced that it was tightening rules on exports of Covid-19 vaccines&comma; sparking an angry response from Britain&period;<&sol;p>&NewLine;<p>Ms Von der Leyen&comma; who has come under intense pressure over the European Commission’s handling of the vaccine orders in recent days&comma; tweeted&colon; &OpenCurlyDoubleQuote;Step forward on vaccines&period;”<&sol;p>&NewLine;<p>The EU is far behind Britain and the United States in getting its population of 450 million vaccinated against the virus&period;<&sol;p>&NewLine;<p>The slow rollout has been blamed on a range of national problems as well as delayed approval of the vaccines compared to elsewhere and an initial shortage of supply&period;<br &sol;>&NewLine;<figure id&equals;"attachment&lowbar;161776" aria-describedby&equals;"caption-attachment-161776" style&equals;"width&colon; 600px" class&equals;"wp-caption aligncenter"><img src&equals;"https&colon;&sol;&sol;londonglossy&period;com&sol;wp-content&sol;uploads&sol;2020&sol;09&sol;ED697C13-A535-4292-8201-38335FD23DB5&period;jpeg" alt&equals;"AstraZeneca&comma; Covid-19&comma; Coronavirus&comma; Vaccine" width&equals;"600" height&equals;"400" class&equals;"size-full wp-image-161776" &sol;><figcaption id&equals;"caption-attachment-161776" class&equals;"wp-caption-text">AstraZeneca said testing has been paused while it investigates &OpenCurlyQuote;a potentially unexplained illness’ associated with its vaccine trials<&sol;figcaption><&sol;figure><br &sol;>&NewLine;The announcement last week that AstraZeneca would initially only supply 31 million doses to the EU’s 27 member states due to production problems triggered a fierce dispute between the two sides&comma; with officials in Brussels saying they feared the company was treating the bloc unfairly compared to other customers&comma; such as the United Kingdom&period;<&sol;p>&NewLine;<p>On Friday&comma; hours after regulators authorised the vaccine for use across the EU&comma; the commission announced that it was tightening rules on exports of Covid-19 vaccines&comma; sparking an angry response from Britain&period;<&sol;p>&NewLine;<p>Under the post-Brexit deal&comma; EU products should still be able to travel unhindered from the bloc to the region&period;<&sol;p>&NewLine;<p>EU member states praised the bloc’s executive branch last year for signing numerous deals with vaccine makers&comma; saying the joint purchase using combined market weight of the entire bloc had ensured a fair distribution for all 27 countries at good prices&period;<&sol;p>&NewLine;<p>In a statement&comma; the European Commission said it planned to set up a specialised body to improve the bloc’s response to health emergency and &OpenCurlyDoubleQuote;deliver a more structured approach to pandemic preparedness”&period;<&sol;p>&NewLine;<p>As part of the effort&comma; together with industry&comma; the EU said it would &OpenCurlyDoubleQuote;fund design and development of vaccines and scale-up manufacturing in the short and medium-term&comma; and also to target the variants of Covid-19&period;”<&sol;p>&NewLine;<p>&OpenCurlyDoubleQuote;The pandemic highlighted that manufacturing capacities are a limiting factor&comma;” it said&period; &OpenCurlyDoubleQuote;It is essential to address these challenges&period;”<&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68e1fba27f575">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68e1fba27f575'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version